Howard J. Dreskin
Corporate Officer/Principal bei Optimer Pharmaceuticals LLC
Profil
Howard J.
Dreskin is currently the Director-Clinical Operations at Optimer Pharmaceuticals LLC since 2007.
Prior to this, he worked as the Director-Clinical Study & Data Management at Pfizer Inc. and as the Associate Director-Worldwide Clinical Safety at Smithkline Beecham Pharmaceuticals (India) Ltd.
He completed his graduate degree from Rutgers State University of New Jersey and his undergraduate degree from the University of Akron.
Aktive Positionen von Howard J. Dreskin
| Unternehmen | Position | Beginn |
|---|---|---|
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Corporate Officer/Principal | 04.05.2011 |
Ehemalige bekannte Positionen von Howard J. Dreskin
| Unternehmen | Position | Ende |
|---|---|---|
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Ausbildung von Howard J. Dreskin
| University of Akron | Undergraduate Degree |
| Rutgers State University of New Jersey | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
